Firebrick Pharma (ASX:FRE) FCF Margin % : 73.86% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Firebrick Pharma's Free Cash Flow for the six months ended in Jun. 2024 was A$-1.33 Mil. Firebrick Pharma's Revenue for the six months ended in Jun. 2024 was A$-1.80 Mil. Therefore, Firebrick Pharma's FCF Margin % for the quarter that ended in Jun. 2024 was 73.86%.

As of today, Firebrick Pharma's current FCF Yield % is -21.78%.

The historical rank and industry rank for Firebrick Pharma's FCF Margin % or its related term are showing as below:

ASX:FRE' s FCF Margin % Range Over the Past 10 Years
Min: -578500 Med: -105875 Max: -15633.33
Current: -16750

During the past 4 years, the highest FCF Margin % of Firebrick Pharma was -15633.33%. The lowest was -578500.00%. And the median was -105875.00%.

ASX:FRE's FCF Margin % is ranked worse than
99.4% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs ASX:FRE: -16750.00

Firebrick Pharma FCF Margin % Historical Data

The historical data trend for Firebrick Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma FCF Margin % Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

FCF Margin %

-105,875.00

-578,500.00

-15,633.33

Firebrick Pharma Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	-	-9,547.83	16,313.64	-55.84	73.86

Competitive Comparison of Firebrick Pharma's FCF Margin %

For the Drug Manufacturers - General subindustry, Firebrick Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firebrick Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's FCF Margin % falls into.

Firebrick Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Firebrick Pharma's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-2.345	/	0.015
	=	-15,633.33 %

Firebrick Pharma's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-1.331	/	-1.802
	=	73.86 %

Firebrick Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma Headlines

No Headlines